AptarGroup, Inc.
ATR Healthcare Medical Instruments & Supplies
AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.
- Revenue
- +6.03%
- EPS
- −73.9%
- Free cash flow
- −16.9%
- Total debt
- +14.6%
Quarter to September 2026, against a year earlier
Follow ATR
Alert me
AptarGroup, Inc. (ATR) P/B ratio
As of 5 November 2026, AptarGroup, Inc. (ATR) trades at a P/B ratio of 3.5×. Over the past ten years it has ranged from 2.7× (November 2025) to 5.4× (May 2021); the current reading is higher than 13% of that period. That is above the Medical Instruments & Supplies industry median of 2.3× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 3.0× | (28.79%) |
| FY2024 | 4.2× | 20.69% |
| FY2023 | 3.5× | (0.38%) |
| FY2022 | 3.5× | (13.96%) |
| FY2021 | 4.1× | (14.95%) |
| FY2020 | 4.8× | 1.91% |
| FY2019 | 4.7× | 13.26% |
| FY2018 | 4.1× | (0.30%) |
| FY2017 | 4.1× | 6.02% |
| FY2016 | 3.9× | (1.25%) |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 2.9× | (2.90%) |
| Jun 2026 | 3.0× | (1.27%) |
| Mar 2026 | 3.0× | 2.13% |
| Dec 2025 | 3.0× | (5.26%) |
| 43 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| BLCO Bausch + Lomb Corporation compare | 1.1× |
| COO The Cooper Companies, Inc. compare | 1.5× |
| AVTR Avantor, Inc. compare | 1.8× |
| BAX Baxter International Inc. compare | 2.0× |
| TFX Teleflex Incorporated compare | 2.3× |
| ALGN Align Technology, Inc. compare | 2.7× |
| SOLV Solventum Corporation compare | 3.1× |
| ATR AptarGroup, Inc. | 3.5× |
| RGEN Repligen Corporation compare | 4.6× |
| Medical Instruments & Supplies industry median | 2.3× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on ATR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement